earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Spyre Therapeutics Inc. (SYRE) SEC filings
Spyre Therapeutics Inc. (SYRE) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B. The SYRE filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Spyre Therapeutics Inc. said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for SYRE — what management said, what changed, and why it matters.
Recent filings
SYRE SEC filings FAQ
What is the latest SYRE SEC filing?
The latest cached Spyre Therapeutics Inc. (SYRE) filing on this page is 8-K · Oct 7, 2026. Filings: https://lician.com/sec/syre
What is the latest SYRE filing accession number?
The latest cached Spyre Therapeutics Inc. (SYRE) accession number on this page is 0001628280-26-065291. Filing: https://lician.com/sec/syre/0001628280-26-065291
Which item codes are on the latest SYRE filing?
Cached item codes on the latest Spyre Therapeutics Inc. (SYRE) 8-K are 1.01, 9.01.
How many SYRE SEC filings are listed on this page?
This page lists 4 cached Spyre Therapeutics Inc. (SYRE) SEC filings. Filings: https://lician.com/sec/syre
What events are listed on the SYRE SEC page?
Cached event headlines on this Spyre Therapeutics Inc. (SYRE) SEC page: "SYRE earnings". Events: https://lician.com/sec/syre
What is SYRE's latest net income?
Latest cached Spyre Therapeutics Inc. (SYRE) net income was -$155.2M. Statements: https://lician.com/financials/syre